Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Cytokinetics

Biotech & Life Sciences · South San Francisco, United States · Founded 1998 · IPO 2004 Unicorn

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$7.80B
Market cap · Apr/2026
Revenue
$88M
Latest reported FY

Investors

4 investors on Cytokinetics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage
Series B+ 3 investors entered at this stage

Global footprint

Where Cytokinetics has talent and traffic

AI talent share
0.5% of workforce is AI talent
(4 of 755 staff)
Core AI20.26%
Other AI20.26%
Non-AI workforce75199.47%
Web traffic by country
220K monthly visits
across markets
🇺🇸 United States92.3%
🇨🇭 Switzerland1.9%
🇬🇧 United Kingdom1.5%
🇨🇦 Canada0.7%
🇮🇳 India0.5%
Top 5 markets shown

See Cytokinetics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.